Total Debt Summary of UniPharma Co., Ltd.

UniPharma Co., Ltd.'s latest annual total debt in 2023 was 277 Thousand TWD , down -92.15% from previous year.
UniPharma Co., Ltd.'s latest quarterly total debt in 2024 Q2 was 12.92 Million TWD , up 28.57% from previous quarter.
UniPharma Co., Ltd. reported annual total debt of 3.52 Million TWD in 2022, down -49.54% from previous year.
UniPharma Co., Ltd. reported annual total debt of 6.99 Million TWD in 2021, down -58.44% from previous year.
UniPharma Co., Ltd. reported quarterly total debt of 12.92 Million TWD for 2024 Q2, up 28.57% from previous quarter.
UniPharma Co., Ltd. reported quarterly total debt of 277 Thousand TWD for 2023 FY, down -92.15% from previous quarter.

Annual Total Debt Chart of UniPharma Co., Ltd. (2023 - 2019)

Name	Total Debt	Total Debt Difference
Allied Biotech Corporation	796.6 Million TWD	99.965%
GeneFerm Biotechnology Co., Ltd.	152.07 Million TWD	99.818%
Easywell Biomedicals, Inc.	386.34 Million TWD	99.928%
TTY Biopharm Company Limited	1.91 Billion TWD	99.986%
Synmosa Biopharma Corporation	2.43 Billion TWD	99.989%
Orient EuroPharma Co., Ltd.	4.84 Billion TWD	99.994%
Center Laboratories, Inc.	5.62 Billion TWD	99.995%
Tien Liang BioTech Co., Ltd.	84.65 Million TWD	99.673%
Orient Pharma Co., Ltd.	716.92 Million TWD	99.961%
InnoPharmax Inc.	21.49 Million TWD	98.712%
Johnson Chemical Pharmaceutical Works Co., Ltd.	160.83 Million TWD	99.828%
Excelsior Biopharma Inc.	377.4 Million TWD	99.927%
DV Biomed Co., Ltd.	387.69 Million TWD	99.929%
Foresee Pharmaceuticals Co., Ltd.	228.25 Million TWD	99.879%
Handa Pharmaceuticals, Inc.	13.24 Million TWD	97.908%
Anxo Pharmaceutical Co., Ltd.	787.84 Million TWD	99.965%
Alar Pharmaceuticals Inc.	1.4 Million TWD	80.341%
Winston Medical Supply Co., Ltd.	107.32 Million TWD	99.742%
Mercury Biopharmaceutical Corporation	42.34 Million TWD	99.346%
Bioray Biotech Co., Ltd	69.79 Million TWD	99.603%
TSH Biopharm Corporation Limited	7.84 Million TWD	96.468%